The Impact of Using a Non-motorised Physical Assistance Device on the Prevention of Musculoskeletal Disorders Amongst Care-givers (TM2S)
This experimental study uses a Single-Case Experimental Design (SCED) with multiple baselines across participants to evaluate the impact of a non motorized assistive device (DAP) on muscle effort in care givers during their professional activities. Each participant completes a 12-day protocol consisting of three phases (A1 - B - A2), with the initial baseline (A1, no device) randomized between 2 and 6 days, followed by a 6-day intervention phase (B, wearing the non-motorized DAP), and a final withdrawal phase (A2, no device) adjusted to complete the 12-day period. Muscle effort is continuously quantified as a percentage of maximum voluntary contraction using mechanomyographic sensors (MOTEN Technologies) placed on the lumbar and biceps muscles, as well as the quadriceps at the Fondation Saint-Hélier site.
研究概览
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Bastien Fraudet
- 电话号码:+33299295043
- 邮箱:bastien.fraudet@fondationsainthelier.com
学习地点
-
-
-
Landivisiau、法国
- Fondation Ildys - EHPAD Saint Vincent
-
接触:
- Manon Le Goff
- 电话号码:+33298028308
- 邮箱:manon.legoff@ildys.org
-
首席研究员:
- Sylvia Courtes
-
Ploemeur、法国、56270
- Centre Mutualiste de Rééducation et de Réadaptation Fonctionnelles (CMRRF) de Kerpape
-
接触:
- Marie Caroline Fortuné
- 电话号码:+33297826023
- 邮箱:marie-caroline.fortune@vyv3.fr
-
首席研究员:
- Cécile Diot
-
Rennes、法国
- Fondation Saint Helier
-
接触:
- Estelle Cézé
- 电话号码:+33299295043
- 邮箱:estelle.ceze@fondationsainthelier.com
-
首席研究员:
- Estelle Cézé
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Aged 18 years and older.
- Height between 160 cm and 200 cm.
- Professional care-giver working in SMR (Medical and Rehabilitation Care) or medico-social departments of partner healthcare facilities.
- Willing to wear the non-motorized DAP under the conditions defined by the protocol.
- Affiliated with or beneficiary of a national social security scheme.
- Having provided free and informed written consent.
Exclusion Criteria:
- Self-reported back, leg, or knee pathology that raises doubts regarding the safe use of the non-motorized DAP without prior medical clearance.
- Pregnant, parturient, or breastfeeding women.
- Persons deprived of liberty by a judicial or administrative decision (including legal guardianship, trusteeship, or court protection).
- Persons receiving psychiatric care or admitted to a healthcare or social establishment for reasons other than research.
- Persons in emergency situations unable to express prior informed consent.
学习计划
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Non-motorized DAP Intervention
Single group following a 12-day A1-B-A2 SCED protocol. Participants undergo a randomized baseline of 2-6 days without the device (A1), a 6-day intervention phase wearing the non-motorized DAP during work activities (B), and an adjusted withdrawal phase without the device (A2). |
Participants wear a non-motorized device for posture assistance (DAP) during their regular professional activities as nurse's aides for 6 consecutive days (Phase B of the 12-day A1-B-A2 SCED protocol). Muscle effort is continuously monitored using mechanomyographic sensors (MOTEN Technologies).
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Percentage of Maximum Voluntary Contraction (% MVC) of target muscle groups
大体时间:Daily during work hours over the 12-day study protocol
|
Muscle effort is continuously quantified via mechanomyography (MMG) using MOTEN Technologies sensors. The primary outcome is the muscle effort level expressed as a percentage of the individual's maximum voluntary contraction (% MVC) for each monitored muscle group (lumbar and biceps muscles across all sites; quadriceps muscles at the Fondation Saint-Hélier site). Measures are compared across the baseline (A1), intervention (B), and withdrawal (A2) phases. |
Daily during work hours over the 12-day study protocol
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Change in postural strain measured by mechanomyography (MMG)
大体时间:Daily during work hours over the 12-day study protocol
|
Postural strain during daily professional activities is evaluated using mechanomyographic (MMG) sensors (MOTEN Technologies) placed on target muscle groups. Measures are compared across the baseline (A1), intervention (B), and withdrawal (A2) phases. |
Daily during work hours over the 12-day study protocol
|
|
Change in perceived effort score using a Numerical Rating Scale (NRS)
大体时间:Twice daily (after each half-day work shift) over the 12-day study protocol
|
Perceived exertion during work tasks is assessed using a 0 to 10 Numerical Rating Scale (NRS/EVN), where 0 represents very low effort and 10 represents very high effort. |
Twice daily (after each half-day work shift) over the 12-day study protocol
|
|
Change in perceived fatigue score using a Numerical Rating Scale (NRS)
大体时间:Twice daily (before and after each full work day) over the 12-day study protocol
|
Subjective physical fatigue is assessed using a 0 to 10 Numerical Rating Scale (NRS/EVN), where 0 represents very low fatigue and 10 represents very high fatigue. |
Twice daily (before and after each full work day) over the 12-day study protocol
|
|
User satisfaction score with the non-motorized DAP (ESAT questionnaire)
大体时间:At the end of Phase B (Day 6 of wearing the device)
|
User satisfaction with the assistive device will be assessed using the 8-item Device subscale of the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0 / ESAT). Items are rated on a 5-point Likert scale from 1 to 5, yielding a total sum score ranging from 8 to 40, where higher scores indicate greater satisfaction |
At the end of Phase B (Day 6 of wearing the device)
|
|
Acceptability score based on the UTAUT model
大体时间:Baseline (prior to Phase A1/B) and Post-Intervention (At the end of day 6 of phase B)
|
Technology acceptance will be assessed across the constructs of the Unified Theory of Acceptance and Use of Technology (UTAUT) questionnaire. Each item is rated on a 7-point Likert scale from 1 (strongly disagree) to 7 (strongly agree). Each item also belongs one of several subscales. Mean scores are calculated separately for each subscale, ranging from 1 to 7, where higher scores indicate greater technology acceptance. |
Baseline (prior to Phase A1/B) and Post-Intervention (At the end of day 6 of phase B)
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 2026-A01360-51
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.